Compound index

Coenzymes & Antioxidants

Nicotinamide adenine dinucleotide

Also known as NAD+ · NAD

Early human trialsInvestigational

Last reviewed: 2026-11-19

Evidence status & limitations

Small human exposure studies mostly measure biomarkers and tolerability; precursor trials cannot be transferred to NAD+ itself.

Regulatory status

No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.

    Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

    WADA prohibited status: current list and context

    Known risks & open questions

    Long-term safety and clinical outcome evidence for external NAD+ remain limited.

    Key sources

    Primary-reference and editorial check: November 19, 2026. Not an exhaustive clinical review; exact formulations and populations matter.

    Related compounds

    • Cyanocobalamin

      Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

    • Glutathione

      Same scientific class · A 3-amino-acid chain. · Early human trials

    Related glossary terms